Engine Biosciences secures $43M for digital drug discovery expansion
Author : Pankaj Singh | Published Date : 2021-05-28
Prominent biotech leader, Engine Biosciences, has reportedly closed $43 million in a funding round led by Polaris Partners, which also saw participation from newcomers, Invus, and a lengthy list of existing investors. The company, a Singaporean outfit, made this move in order to keep growing in the field of drug discovery.
Notably, the money would be used in requisite testing and the paperwork which is involved in bringing a novel drug to the market on the basis of promising leads.
For the record, digital drug discovery is the large-scale analysis of biological data, including genes, binding sites, gene expression, protein structures, among others.
The company would be making use of a pair of tools, which it has named NetMAPPR and CombiGEM. While NetMAPPR would take special note of the errors to deliver a foothold for the treatment or molecule, CombiGEM would provide an instantaneous experimental confirmation of the targets as well as effects proposed by the digital side.
According to the Co-founder and CEO of Engine Biosciences, Jeffrey Lu, the company’s focus on gene interactions would set their approach apart. He has apparently claimed that the team is working towards a proven approach in cancer for effective precision medicines while considering the relevancy of gene interactions to all diseases.
The CEO confirmed that the team was already in possession of the chemical compounds, effectively the prototype drugs that show anti-cancer effects in diseased cells, which are directed towards the novel biology that the company has uncovered.
Sources also reveal that Engine is currently teaming up with other firms to advance its steps in automated animal testing, in order to forge a path for human trials.
Previously, the company had also raised a $10 million seed in 2018 and has been consistent in its activities. However, it would require more funding for bringing these developments to the market.
Source Credits
About Author
Pankaj Singh . .
Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605
Related News
Bayers new CEO initiates management job cuts to accelerate decision-making
Bayer newly appointed CEO, Bill Anderson, has reportedly unveiled plans to streamline the companys management structure in a bid to expedite decision-making processes. This marks the first step in a broader effort to transform the embattled German company, which has been under pressure from inv... Read More>>
Smurfit Kappa in Merger Talks with WestRock worth $19 Billion
Smurfit Kappa, a prominent player in the packaging industry, is reportedly engaged in merger discussions with its US counterpart, WestRock. This prospective merger has the potential to create a cardboard box-making powerhouse boasting a market value approaching $19 billion (€17.8 billion). Furt... Read More>>
RBC plans job cuts to take on anticipated economic softening
The Royal Bank of Canada is reportedly planning to reduce its workforce by approximately 1,800 jobs as part of cost-cutting measures, on account of the anticipated upcoming economic landscape. This decision comes after the country's largest bank surpassed analysts' predictions for the third ... Read More>>